Skip to main content
Glama

Linkedin Humblebrag

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
      -  "company"
      -]New value: +[
      +  "company",
      +  "drug"
      +]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.6/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already signal read-only/idempotent behavior, and the description adds substantial context: cascading internal lookups across EDGAR/GLEIF/OpenFIGI, graceful degradation if enrichment sources fail, explicitly listing unresolved identifiers, returning figi_candidates for ambiguous matches, and ISIN-to-LEI resolution. This far exceeds what the annotations alone convey.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with the core purpose and trigger phrases, but it quickly becomes a dense, run-on wall of parentheticals and nested clauses. Most content is relevant, but the structure makes it harder for an agent to parse quickly than it needs to be.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the full burden of explaining return expectations, and it largely succeeds: it lists returned identifier types per entity kind, the unresolved field, figi_candidates, enrichment fallback, and the internal cascade behavior. An agent has enough information to call and interpret the tool correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Although schema coverage is 100%, the description meaningfully enriches value semantics: it adds ISIN as a valid company input, distinguishes exact-ticker mapping from name search, explains how issuer names map to FIGI lookups, and warns against trailing security-class words. This is valuable guidance beyond the schema's brief parameter descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific verb and resource (resolve user-spoken names to canonical/official identifiers) and anchors it with concrete trigger phrases like 'What's the ticker for…'. It clearly positions the tool as the first stop when a name needs an ID, so an agent can distinguish its role from the sibling listing.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It gives an explicit rule ('Use FIRST whenever you have a name but need an ID') plus rich examples of when the tool applies, including bonds, drugs, and ISIN lookups. It does not name specific sibling tools or give explicit when-not-to-use conditions, so it stops short of a full 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation3/5

Most tools are distinctly named and the descriptions are unusually specific, but the set contains overlapping families: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, and deep_research all route to the same underlying data, and the beta variant is currently an exact duplicate. The entity/company lookup, AI-visibility, and Polymarket clusters also require reading the long descriptions to choose correctly.

Naming Consistency3/5

All names are lowercase snake_case and readable, with useful prefixes like ask_pipeworx, polymarket_, and pipeworx_. However the macro pattern is mixed: many are verb-first (compare_entities, resolve_entity), many are noun phrases (entity_profile, polymarket_edge_tracker, recent_alerts), and one puts the verb last (linkedin_humblebrag_generate).

Tool Count2/5

32 tools is far too many for a server whose apparent name and stated LinkedIn-humblebrag purpose are served by exactly one tool. Even viewed as a general Pipeworx/research utility, the surface is bloated: duplicate ask variants, multiple meta-tools, and a sprawling prediction-market family push the count well past the 25-tool threshold.

Completeness2/5

For the domain implied by the server name, the surface is severely incomplete: only generation exists, with no way to list, edit, delete, publish, or manage LinkedIn-humblebrag posts. The de facto Pipeworx research domain is much better covered, but the overall set has serious dead ends because the one LinkedIn tool is isolated and the core tools are oriented toward a different, unrelated workflow.